|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication October 20, 2004.
Revised January 9, 2005.
Accepted for publication February 8, 2005.
We have used site-directed mutagenesis of amino acids located within the S1 and S2 ligand binding domains of the NR2A NMDA receptor subunit to explore the nature of ligand binding. Wild-type or mutated NR1/NR2A NMDA receptors were expressed in Xenopus laevis oocytes and studied using TEVC. We investigated the effects of mutations in the S1 and S2 regions on the potencies of the agonists L-glutamate, L-aspartate, RS-tetrazol-5-yl glycine and NMDA. Mutation of each of the corresponding residues found in the NR2A receptor subunit, suggested to be contact residues in the GluR2 AMPA receptor subunit, caused a rightward shift in the concentration-response curve for each agonist examined. None of the mutations examined altered the efficacy of glutamate as assessed by MTSEA potentiation of agonist-evoked currents. In addition none of the mutations altered the potency of glycine. Homology modeling and molecular dynamics were used to evaluate molecular details of ligand binding of both wild-type and mutant receptors, as well as to explore potential explanations for agonist selectivity between glutamate receptor subtypes. Our modeling studies support our interpretation of the mutagenesis data and indicate a similar binding strategy for L-glutamate and NMDA when they occupy the binding site in NMDA receptors as has been proposed for glutamate binding to the GluR2 AMPA receptor subunit. Furthermore, we offer an explanation as to why 'charge conserving' mutations of two residues in the binding pocket result in non-functional receptor-channels and suggest a contributing molecular determinant of why NMDA is not an agonist at AMPA receptors.
Key words:
Glutamate, Molecular dynamics, Structure-activity relationships and modeling, Func. analysis receptor/ion channel mutants, Mutagenesis/Chimeric approaches
This article has been cited by other articles:
![]() |
M. L. Blanke and A. M. J. VanDongen Constitutive Activation of the N-Methyl-D-aspartate Receptor via Cleft-spanning Disulfide Bonds J. Biol. Chem., August 1, 2008; 283(31): 21519 - 21529. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Blanke and A. M. J. VanDongen The NR1 M3 Domain Mediates Allosteric Coupling in the N-Methyl-D-aspartate Receptor Mol. Pharmacol., August 1, 2008; 74(2): 454 - 465. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-R. Chang and C.-C. Kuo The Activation Gate and Gating Mechanism of the NMDA Receptor J. Neurosci., February 13, 2008; 28(7): 1546 - 1556. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Wrighton, E. J. Baker, P. E. Chen, and D. J. A. Wyllie Mg2+ and memantine block of rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes J. Physiol., January 1, 2008; 586(1): 211 - 225. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Chen, M. T. Geballe, E. Katz, K. Erreger, M. R. Livesey, K. K. O'Toole, P. Le, C. J. Lee, J. P. Snyder, S. F. Traynelis, et al. Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes J. Physiol., January 1, 2008; 586(1): 227 - 245. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Erreger, M. T. Geballe, A. Kristensen, P. E. Chen, K. B. Hansen, C. J. Lee, H. Yuan, P. Le, P. N. Lyuboslavsky, N. Micale, et al. Subunit-Specific Agonist Activity at NR2A-, NR2B-, NR2C-, and NR2D-Containing N-Methyl-D-aspartate Glutamate Receptors Mol. Pharmacol., October 1, 2007; 72(4): 907 - 920. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-R. Chang and C.-C. Kuo Characterization of the Gating Conformational Changes in the Felbamate Binding Site in NMDA Channels Biophys. J., July 15, 2007; 93(2): 456 - 466. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Maier, R. Schemm, C. Grewer, and B. Laube Disruption of Interdomain Interactions in the Glutamate Binding Pocket Affects Differentially Agonist Affinity and Efficacy of N-methyl-D-aspartate Receptor Activation J. Biol. Chem., January 19, 2007; 282(3): 1863 - 1872. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Wada, H. Takahashi, S. A. Lipton, and H.-S. V. Chen NR3A Modulates the Outer Vestibule of the "NMDA" Receptor Channel J. Neurosci., December 20, 2006; 26(51): 13156 - 13166. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Frizelle, P. E. Chen, and D. J. A. Wyllie Equilibrium Constants for (R)-[(S)-1-(4-Bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic Acid (NVP-AAM077) Acting at Recombinant NR1/NR2A and NR1/NR2B N-Methyl-D-aspartate Receptors: Implications for Studies of Synaptic Transmission Mol. Pharmacol., September 1, 2006; 70(3): 1022 - 1032. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. A. Wyllie, A. R. Johnston, D. Lipscombe, and P. E. Chen Single-channel analysis of a point mutation of a conserved serine residue in the S2 ligand-binding domain of the NR2A NMDA receptor subunit J. Physiol., July 15, 2006; 574(2): 477 - 489. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Hansen, R. P. Clausen, E. J. Bjerrum, C. Bechmann, J. R. Greenwood, C. Christensen, J. L. Kristensen, J. Egebjerg, and H. Brauner-Osborne Tweaking Agonist Efficacy at N-Methyl-D-aspartate Receptors by Site-Directed Mutagenesis Mol. Pharmacol., December 1, 2005; 68(6): 1510 - 1523. [Abstract] [Full Text] [PDF] |
||||